Abogen has been invited to present at RNA Leaders Europe 2026 in Vienna, Austria, from March 17–19. 

Dr. Bo Ying, CEO of Abogen, will join global industry leaders to discuss the transformative technologies in RNA drug discovery and vaccine development. He will present latest clinical updates for drug candidates developed leveraging our proprietary mRNA+LNP platform, plus latest data on mRNA cancer vaccines.

Abogen’s Speaking Session:

1. Keynote Panel
Topic: The Potential of RNA Therapeutics - Rare vs Broad Spectrum Conditions
Date&Time: Mar 18, 2026, 9:30-10:15 AM

2. Presentation
Topic: Unlocking Recent Clinical Progress of mRNA-Based Cancer Vaccines & B-Cell Depletion Therapies
Date&Time: Mar 18, 2026, 11:00-11:30 AM
Highlight:
① Demonstrating Abogen's unique mRNA and LNP platform
② Sharing clinical data and progress of mRNA cancer vaccines
③ Accelerating preclinical and clinical development of mRNA-based T cell engagers